AU2002362537A1 - A method of detecting intracellular protein-protein interactions using three heterologous conjugates - Google Patents

A method of detecting intracellular protein-protein interactions using three heterologous conjugates

Info

Publication number
AU2002362537A1
AU2002362537A1 AU2002362537A AU2002362537A AU2002362537A1 AU 2002362537 A1 AU2002362537 A1 AU 2002362537A1 AU 2002362537 A AU2002362537 A AU 2002362537A AU 2002362537 A AU2002362537 A AU 2002362537A AU 2002362537 A1 AU2002362537 A1 AU 2002362537A1
Authority
AU
Australia
Prior art keywords
protein
detecting intracellular
heterologous conjugates
interactions
protein interactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002362537A
Inventor
Soren Jensby Nielsen
Bernard Robert Terry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioImage AS
Original Assignee
BioImage AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioImage AS filed Critical BioImage AS
Publication of AU2002362537A1 publication Critical patent/AU2002362537A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
AU2002362537A 2001-10-01 2002-10-01 A method of detecting intracellular protein-protein interactions using three heterologous conjugates Abandoned AU2002362537A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200101433 2001-10-01
DKPA200101433 2001-10-01
US32889601P 2001-10-11 2001-10-11
US60/328,896 2001-10-11
PCT/DK2002/000651 WO2003029827A2 (en) 2001-10-01 2002-10-01 A method of detecting intracellular protein-protein interactions using three heterologous conjugates

Publications (1)

Publication Number Publication Date
AU2002362537A1 true AU2002362537A1 (en) 2003-04-14

Family

ID=26069071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002362537A Abandoned AU2002362537A1 (en) 2001-10-01 2002-10-01 A method of detecting intracellular protein-protein interactions using three heterologous conjugates

Country Status (5)

Country Link
US (1) US20030143634A1 (en)
EP (1) EP1440319A2 (en)
AU (1) AU2002362537A1 (en)
CA (1) CA2462598A1 (en)
WO (1) WO2003029827A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050214738A1 (en) * 2003-11-19 2005-09-29 Kryn Stankunas Conditional allele system
WO2006012309A1 (en) * 2004-06-25 2006-02-02 Cold Spring Harbor Laboratory Inducible inactivation of synaptic transmission
JP5406019B2 (en) 2006-05-17 2014-02-05 セルーメン、インコーポレイテッド Method for automated tissue analysis
US20100112602A1 (en) * 2006-11-10 2010-05-06 Taylor Lansing D Protein-Protein Interaction Biosensors and Methods of Use Thereof
CA2830501C (en) 2011-03-17 2023-10-17 Cernostics, Inc. Systems and compositions for diagnosing barrett's esophagus and methods of using the same
KR101212029B1 (en) * 2011-12-20 2012-12-13 한국기초과학지원연구원 Method for detecting interactions between molecular compound and its binding proteins
EP3663405A1 (en) 2013-06-11 2020-06-10 Takara Bio USA, Inc. Protein enriched microvesicles and methods of making and using the same
WO2017024317A2 (en) * 2015-08-06 2017-02-09 Dana-Farber Cancer Institute, Inc. Methods to induce targeted protein degradation through bifunctional molecules
CN111986069A (en) * 2019-05-22 2020-11-24 三星电子株式会社 Image processing apparatus and image processing method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2139329T3 (en) * 1995-09-22 2000-02-01 Bioimage A S NEW VARIANTS OF GREEN FLUORESCENT PROTEIN, GFP.
US5861239A (en) * 1996-04-12 1999-01-19 Millennium Pharmaceuticals, Inc. Methods for identifying compounds that modulate mammalian tub protein activity
US5739310A (en) * 1996-04-23 1998-04-14 Fred Hutchinson Cancer Research Center Ribosomes as vectors for RNA
US6124128A (en) * 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
JP2003524368A (en) * 1997-08-26 2003-08-19 アリアド ジーン セラピューティクス インコーポレイテッド Fusion protein comprising a dimerization domain, a trimerization domain or a tetramerization domain and a complementary heterologous transcriptional activation domain, a transcription repression domain, a DNA binding domain or a ligand binding domain
EP1115734A4 (en) * 1998-09-24 2004-07-21 Univ Duke Method of measuring protein-protein interactions in living cells
US7282347B2 (en) * 2000-07-04 2007-10-16 Fisher Bioimage Aps Method for extracting quantitative information relating to interactions between cellular components

Also Published As

Publication number Publication date
US20030143634A1 (en) 2003-07-31
WO2003029827A3 (en) 2003-11-13
CA2462598A1 (en) 2003-04-10
EP1440319A2 (en) 2004-07-28
WO2003029827A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AUPR863401A0 (en) A method & device for precision time-lock
AU2003219277A1 (en) Intracellular antibodies
AU2001232987A1 (en) A method for forming a micromechanical device
AU2002362869A1 (en) A handover method
AU2002323514A1 (en) A method of fabrication of a sensor
AUPQ687600A0 (en) A method of detection
EP2190002B8 (en) Method for detecting a fine geometry
AU2002362537A1 (en) A method of detecting intracellular protein-protein interactions using three heterologous conjugates
AUPR343601A0 (en) Trenching machine
AU2002255105A1 (en) Intracellular analysis
AU4891101A (en) Method for forming a three-dimensional construction
AU2003255554A1 (en) A method for bricklaying
AUPR858301A0 (en) An impactor anvil
AU2001238092A1 (en) A speaker alignment tool
AU2002237270A1 (en) Means for initiating a self-test
AUPQ781100A0 (en) A method of detection
AU2001284270A1 (en) A position determining apparatus
AUPQ680300A0 (en) A method
AU2002219018A1 (en) A method of weighing objects
AU2002242750A1 (en) Determining a position of objects
AUPR669401A0 (en) A site development method
AU2002331593A1 (en) A method of measuring solubility
AU2001266015A1 (en) Method for detecting fungicides
AU2002231901A1 (en) Position-finding method for positioning a necktie
AUPR460801A0 (en) A method of detection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase